Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/65819
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Todder, D. | - |
dc.contributor.author | Baune, B. | - |
dc.date.issued | 2007 | - |
dc.identifier.citation | Journal of Medical Case Reports, 2007; 1(166):1-4 | - |
dc.identifier.issn | 1752-1947 | - |
dc.identifier.issn | 1752-1947 | - |
dc.identifier.uri | http://hdl.handle.net/2440/65819 | - |
dc.description.abstract | This report describes a patient suffering from panic disorder who developed repeated suicidal ideation specifically due to the treatment with Venlafaxine. A first suicide attempt years ago occurred while being treated with Venlafaxine. Subsequent treatment with SSRIs or other antidepressants involved no suicidal ideation. Re-commencement of Venlafaxine four years later immediately led to a second suicide attempt. This unwanted effect subsided immediately after switching to another SNRI (i.e. Duloxetine). The case report underlines the importance of onset of suicide risk in panic disorders due to specific antidepressants. | - |
dc.description.statementofresponsibility | Doron Todder and Bernhard T Baune | - |
dc.language.iso | en | - |
dc.publisher | BioMed Central Ltd | - |
dc.rights | © 2007 Todder and Baune; licensee BioMed Central Ltd. | - |
dc.source.uri | http://www.jmedicalcasereports.com/content/1/1/166 | - |
dc.title | Recurrence of suicidal ideation due to treatment with antidepressants in anxiety disorder: a case report | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1186/1752-1947-1-166 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Baune, B. [0000-0001-6548-426X] | - |
Appears in Collections: | Aurora harvest Psychiatry publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.